Observations on recent studies showing increased co-occurrence of autoimmune diseases

Journal of Autoimmunity

Volumn 18, Issue 3, 2002, Pages 251-257

  Sloka, Scott ^a,b  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b NONE   (Canada)

Author keywords

Autoimmunity; Co occurrence; Epidemiological study design

Indexed keywords

ADDISON DISEASE; ARTICLE; COMPARATIVE STUDY; GRAVES DISEASE; GUILLAIN BARRE SYNDROME; HASHIMOTO DISEASE; HISTORY; HUMAN; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; OBSERVATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0036591272     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2002.0588     Document Type: Article

References (56)

1. Davidson A., Diamond B. Autoimmune diseases. N. Engl. J. Med. 345:2001;340-350.
2. Broadley S.A., Deans J., Sawcer S.J., Clayton D., Compston D.A. Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey. Brain. 123:2000;1102-1111.
3. Karni A., Abramsky O. Association of MS with thyroid disorders. Neurology. 53:1999;883-885.
4. Roquer J., Escudero D., Herraiz J., Maso E., Cano F. Multiple sclerosis and Hashimoto's thyroiditis. J. Neurol. 234:1987;23-24.
5. Seissler J., de Sonnaville J.J., Morgenthaler N.G., Steinbrenner H., Glawe D., Khoo-Morgenthaler U.Y. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease. Diabetologia. 41:1998;891-897.
6. Gatling W., Budd S., Walters D., Mullee M.A., Goddard J.R., Hill R.D. Evidence of an increasing prevalence of diagnosed diabetes mellitus in the Poole area from 1983 to 1996. Diabet. Med. 15:1998;1015-1021.
7. Onkamo P., Vaananen S., Karvonen M., Tuomilehto J. Worldwide increase in incidence of Type I diabetes - the analysis of the data on published incidence trends. Diabetologia. 42:1999;1395-1403.
8. Zimmet P.Z., Tuomi T., Mackay I.R., Rowley M.J., Knowles W., Cohen M. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet. Med. 11:1994;299-303.
9. Ziegler A.G., Hummel M., Schenker M., Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes. 48:1999;460-468.
10. Colman P.G., Steele C., Couper J.J., Beresford S.J., Powell T., Kewming K. Islet autoimmunity in infants with a Type I diabetic relative is common but is frequently restricted to one autoantibody. Diabetologia. 43:2000;203-209.
11. Atkinson M.A., Eisenbarth G.S. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 358:2001;221-229.
12. Larsen J.P., Kvaale G., Riise T., Nyland H., Aarli J.A. Multiple sclerosis - more than one disease? Acta Neurol. Scand. 72:1985;145-150.
13. Weinshenker B.G. Progressive forms of MS: classification streamlined or consensus overturned? Lancet. 355:2000;162-163.
14. Lublin F.D., Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 46:1996;907-911.
15. Kremenchutzky M., Cottrell D., Rice G., Hader W., Baskerville J., Koopman W. The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. Brain. 122:1999;1941-1950.
16. Thompson A.J., Polman C.H., Miller D.H., McDonald W.I., Brochet B., Filippi M.M. Primary progressive multiple sclerosis. Brain. 120:1997;1085-1096.
17. Prat A., Pelletier D., Duquette P., Arnold D.L., Antel J.P. Heterogeneity of T-lymphocyte function in primary progressive multiple sclerosis: relation to magnetic resonance imaging lesion volume. Ann. Neurol. 47:2000;234-237.
18. Olerup O., Hillert J., Fredrikson S., Olsson T., Kam-Hansen S., Moller E. Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc. Natl. Acad. Sci. USA. 86:1989;7113-7117.
19. Weinshenker B.G., Santrach P., Bissonet A.S., McDonnell S.K., Schaid D., Moore S.B. Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology. 51:1998;742-747.
20. Hillert J., Gronning M., Nyland H., Link H., Olerup O. An immunogenetic heterogeneity in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 55:1992;887-890.
21. Rovaris M., Bozzali M., Santuccio G., Iannucci G., Sormani M.P., Colombo B. Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis. J. Neurol. Neurosurg. Psychiatry. 69:2000;723-727.
22. Lucchinetti C., Bruck W., Noseworthy J. Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment. Curr. Opin. Neurol. 14:2001;259-269.
23. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain. 122:1999;2279-2295.
24. She J.X. Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol. Today. 17:1996;323-329.
25. Christie M.R., Vohra G., Champagne P., Daneman D., Delovitch T.L. Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment. J. Exp. Med. 172:1990;789-794.
26. Cetani F., Barbesino G., Borsari S., Pardi E., Cianferotti L., Pinchera A. A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. J. Clin. Endocrinol. Metab. 86:2001;4747-4752.
27. Ahonen P. Autoimmune polyendocrinopathy - candidosis - ectodermal dystrophy (APECED): autosomal recessive inheritance. Clin. Genet. 27:1985;535-542.
28. Zlotogora J., Shapiro M.S. Polyglandular autoimmune syndrome type I among Iranian Jews. J. Med. Genet. 29:1992;824-826.
29. Fleiss J.L. Statistical Methods for Rates and Proportions. Second ed. Wiley Series in Probability and Mathematical Statistics. 1981.
30. Tunbridge W.M., Evered D.C., Hall R., Appleton D., Brewis M., Clark F. The spectrum of thyroid disease in a community: the Whickham survey. Clin. Endocrinol. (Oxf). 7:1977;481-493.
31. de Andres C., Guillem A., Rodriguez-Mahou M., Lopez Longo F.J. Frequency and significance of anti-Ro (SS-A) antibodies in multiple sclerosis patients. Acta Neurol. Scand. 104:2001;83-87.
32. Miro J., Pena-Sagredo J.L., Berciano J., Insua S., Leno C., Velarde R. Prevalence of primary Sjogren's syndrome in patients with multiple sclerosis. Ann. Neurol. 27:1990;582-584.
33. Furszyfer J., Kurland L.T., McConahey W.M., Woolner L.B., Elveback L.R. Epidemiologic aspects of Hashimoto's thyroiditis and Graves' disease in Rochester, Minnesota (1935-1967), with special reference to temporal trends. Metabolism. 21:1972;197-204.
34. Gaches F., Delaire L., Nadalon S., Loustaud-Ratti V., Vidal E. [Frequency of autoimmune diseases in 218 patients with autoimmune thyroid pathologies]. Rev. Med. Interne. 19:1998;173-179.
35. Agard C., Chaillous L., Murat A., Tranchant D., Charbonnel B. [Postpartum thyroiditis and Basedow disease]. Presse. Med. 26:1997;1095-1097.
36. Kasuga Y., Kobayashi S., Fujimori M., Shingu K., Hama Y., Maruyama M. Development of Graves' disease from asymptomatic autoimmune thyroiditis: a case report. Endocr. J. 43:1996;743-746.
37. Gillis D., Volpe R., Daneman D. A young boy with a thyroid yo-yo. J. Pediatr. Endocrinol. Metab. 11:1998;467-470.
38. Valentino R., Savastano S., Tommaselli A.P., Dorato M., Scarpitta M.T., Gigante M. Unusual association of thyroiditis, Addison's disease, ovarian failure and celiac disease in a young woman. J. Endocrinol. Invest. 22:1999;390-394.
39. Forster G., Krummenauer F., Kuhn I., Beyer J., Kahaly G. [Polyglandular autoimmune syndrome type II: epidemiology and forms of manifestation]. Dtsch Med. Wochenschr. 124:1999;1476-1481.
40. Mihailova D., Grigorova R., Vassileva B., Mladenova G., Ivanova N., Stephanov S. Autoimmune thyroid disorders in juvenile chronic arthritis and systemic lupus erythematosus. Adv. Exp. Med. Biol. 455:1999;55-60.
41. Sierra S.L., Sendino R.A., Pacheco C.R., Aparicio J.G., Barbado Hernandez F.J. [Hashimoto's thyroiditis and Sjogren syndrome. Association or autoimmune multiple syndrome?]. An. Med. Interna. 18:2001;86-87.
42. Mazanek E., Zalewski J., Starzewska H. [Hyperthyroidism in 3 patients with Addison's disease]. Wiad. Lek. 30:1977;1833-1834.
43. Rodrigue S., Laborde H., Catoggio P.M. Systemic lupus erythematosus and thyrotoxicosis: a hitherto little recognised association. Ann. Rheum. Dis. 48:1989;424-427.
44. Scofield R.H. Autoimmune thyroid disease in systemic lupus erythematosus and Sjogren's syndrome. Clin. Exp. Rheumatol. 14:1996;321-330.
45. Paradowski B., Koszewicz M., Grodzicka I. [Chronic demyelinative polyneuropathy Guillain-Barre type in the course of systemic lupus erythematosus]. Pol. Merkuriusz Lek. 10:2001;105-106.
46. Pryszmont M., Sierakowski S., Poplawska T., Domyslawska I., Pryszmont J., Pawlak-Tumiel B. [Guillain-Barre syndrome in a patient with primary sicca syndrome]. Neurol. Neurochir. Pol. 34:2000;1235-1241.
47. Koren S., Hanly J.G. Adrenal failure in systemic lupus erythematosus. J. Rheumatol. 24:1997;1410-1412.
48. Seinfeld E.D., Sharma O.P. TASS syndrome: unusual association of thyroiditis, Addison's disease, Sjogren's syndrome and sarcoidosis. J. R. Soc. Med. 76:1983;883-885.
49. Miyagawa S., Nakajima M., Nishio K., Sogami J., Tsubakimoto A., Yoshioka A. Guillain-Barre syndrome in a child with systemic lupus erythematosus and anti-Ro/SSA and anti-La/SSB autoantibodies. Br. J. Dermatol. 143:2000;1050-1054.
50. McDonagh J.E., Isenberg D.A. Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus. Ann. Rheum. Dis. 59:2000;230-232.
51. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 343:2000;938-952.
52. Weetman A.P. Graves' disease. N. Engl. J. Med. 343:2000;1236-1248.
53. Vaidya B., Imrie H., Geatch D.R., Perros P., Ball S.G., Baylis P.H. Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease. J. Clin. Endocrinol. Metab. 85:2000;688-691.
54. Dayan C.M., Daniels G.H. Chronic autoimmune thyroiditis. N. Engl. J. Med. 335:1996;99-107.
55. Mills J.A. Systemic lupus erythematosus. N. Engl. J. Med. 330:1994;1871-1879.
56. Seneviratne U. Guillain-Barre syndrome. Postgrad. Med. J. 76:2000;774-782.